1 citations
,
April 2019 in “Acta medica Philippina” This study found that androgenetic alopecia is significantly associated with an increased risk of Metabolic Syndrome, particularly in early-onset male cases and females exhibiting severe AGA.
1 citations
,
January 2015 in “Journal of Clinical Toxicology” In this study, paternal exposure to finasteride prior to or during pregnancy was linked to a majority of normal full-term births, although some cases resulted in abortions, aligning with previous animal study findings.
June 2026 in “International Journal of Ayurvedic Medicine” This randomized clinical trial observed that Facia Men’s capsule significantly reduced hair shedding in men with androgenetic alopecia over 12 weeks without affecting renal or liver function, though a small change in blood glucose suggests monitoring metabolic health.
June 2026 in “Research Square” This study found that lower vitamin D levels were inversely associated with the severity of female pattern hair loss and patchy alopecia areata, but not with telogen effluvium.
This case study describes a 34-year-old male developing painful inflammatory scalp nodules post-scalp microinfusion of medication. The findings suggest that repeated microtrauma or bacterial colonization might trigger dissecting cellulitis in susceptible individuals, with exogenous testosterone as a potential modifier, not a direct cause.
In this study, microneedling radiofrequency followed by topical exosome application was associated with significant increases in hair density and diameter, showing promising potential as a therapy for pattern hair loss.
May 2025 in “International Journal of Trichology” The examined study explored how trichoscopic evaluations of female pattern hair loss might relate to disease severity and histological changes, but the authors highlighted methodological issues such as unclear sample size determination and insufficient control of confounding variables, which limit the results' generalizability and reproducibility.
January 2025 in “JCEM Case Reports” In this case report, researchers described a patient with Cushing's Disease exhibiting no detectable mass, where Metyrapone therapy was effectively used to manage symptoms, suggesting a treatment option for similar diagnostic challenges.
September 2024 in “Egyptian Journal of Dermatology and Venerology” In this interventional study on female-pattern hair loss, researchers found that fractional CO2 laser therapy alone improved hair growth, as evidenced by increased hair count, thickness, density, and patient satisfaction compared to saline controls. However, the precise mechanisms behind these effects require further investigation.
June 2024 in “Indian Journal of Plastic Surgery/Indian journal of plastic surgery” This study found that using a specific ratio method based on the patient's scalp measurements can effectively predict the dimensions of the permanent safe zone for hair transplants, particularly in early stages of androgenetic alopecia, potentially ensuring long-lasting transplant results.
January 2024 in “International Ayurvedic medical journal” This study explores how Ayurveda concepts, specifically Prakruti, relate to male pattern baldness, suggesting that individual constitutional types may predict susceptibility to earlier hair loss when influenced by modern lifestyle factors.
January 2024 in “Journal of Cosmetics, Dermatological Sciences and Applications” This study found that electronically-operated pneumatic injections for administering a peptide-hyaluronic acid combination were well tolerated and led to significant improvement in hair density and thickness for men with androgenic alopecia over six months, though the exact mechanism remains uncertain.
July 2023 in “Deleted Journal” This study reported a higher prevalence of androgenetic alopecia in male respondents compared to female respondents in different regions of Saudi Arabia.
This review discusses the genetic differences between male and female pattern hair loss and highlights the uncertainty surrounding genetic factors in female pattern hair loss, but reports no clinical results.
February 2020 in “International Journal of Research in Dermatology” This study found that platelet-rich plasma therapy showed varying levels of improvement in patients with androgenetic alopecia, though it is not yet considered evidence-based for this condition.
January 2020 in “International journal of scientific research” Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.
January 2020 in “Journal of Cosmetics, Dermatological Sciences and Applications” In a 3-month study, over 90% of healthy women experiencing self-perceived hair thinning reported that the nutritional supplement DEEPLY ROOTED improved their hair growth, volume, and quality, without significant adverse effects.
January 2019 in “Indian Dermatology Online Journal” This commentary discusses the need for community dermatology initiatives in developing countries to improve skin health awareness and addresses how outreach events can provide valuable insights into common dermatological conditions.
September 2017 in “Springer eBooks” PRP injection therapy shows promise for treating hair loss, increasing hair count and thickness with minimal side effects.
January 2016 in “Archivio italiano di urologia, andrologia” This article reviews treatment-induced sexual dysfunctions related to 5-alpha-reductase inhibitors and reports no new results; it highlights the need to better define and understand this controversial topic.
September 2015 in “British Journal of Dermatology” Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.
January 2014 in “Journal of Pigmentary Disorders” This review discusses age-related and environmental factors affecting scalp hair changes in women, highlighting diagnostic complexities and ongoing research into targeted treatments, without reporting new clinical results.
March 2012 in “Journal of The American Academy of Dermatology” Hair casts are often mistaken for head lice, scalp pain in hair loss is linked to certain nerve factors, eyelash growth treatment is safe and effective, and nail shedding in children may follow hand-foot-mouth disease.
March 2012 in “Journal of The American Academy of Dermatology” Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.
October 2008 in “Australasian Journal of Dermatology” This article provides a multiple-choice quiz based on dermatology information but shares no new research findings.
November 2025 in “Turkish Journal of Dermatology” This study found that both follicular unit transplantation (FUT) and follicular unit extraction (FUE) are safe and effective for female pattern hair loss, with FUE offering broader indications and higher patient satisfaction.
August 2024 in “Indian Dermatology Online Journal” In this retrospective study, researchers described the dermoscopic features of dermatitis cruris pustulosa et atrophicans in 30 patients, finding that follicular-based pustules and other specific features were predominant, with male patients being more affected and primarily involving the lower extremities.
2 citations
,
July 2024 in “Indian Journal of Dermatology” In this study, researchers found that adults with alopecia areata exhibited trichoscopic features of empty follicular openings and tulip hair, while children showed more honeycomb pigment patterns and pohlpinkus constriction on their scalp lesions.
September 2025 in “Medicine” This study found that male patients with androgenetic alopecia exhibited signs of increased arrhythmia risk, such as higher P-wave dispersion and lower corrected QT interval on ECG, suggesting potential benefits from closer cardiac monitoring.
16 citations
,
June 2008 in “Springer eBooks” Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.